This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The computational chemistry firm Schrödinger argues that AI isn’t enough in drug...
Origins of drugmakers’ unusual monikers and why cooks might want a rotovap
After a breakdown in US-Russia relations, Riken finds itself ahead of its rivals...
New labeling method lights up deep brain regions
Meeting cancellations at US health agency force pause in grant reviews
Leukemia patients may respond better to immunotherapy with a diverse microbiome
New laws and evolving technologies for breaking down polyurethanes aim to create...
MIT professor is passionate about reducing the chemical industry’s impact on the...
This year will be the 100th anniversary of the biennial event
Unlike popular GLP-1 agonists, Helicore’s lead asset targets GIP receptors
Some of these mice survive into adulthood, which has not previously been managed
Under pressure from its largest shareholder, the firm has unveiled reforms
Acting NIH director Memoli clarifies communication restrictions as White House m...
Targeting voltage-gated sodium channels could usher in new opioid-free solutions...
Vertex’s suzetrigine is a paradigm shift in pain management, the firm’s CEO says
UV radiation may have influenced the timeline of genetic material’s emergence
Test your knowledge of the science, development, and risks of these drugs